Studied patients with RRMS, 18-45, EDSS 0-5, 2 exacerbations or more in 2 years, stable for thirty days. 251 patients (73 percent female) with endpoint relapse rate. Exacerbation rate decreased significantly, disability not robust data. Confirmed progression of not close to significance but EDSS was marginally significant.
The followup study with MRI European/Canadian confirmed a 33 % reduction in exacerbations, and a 35 % reduction in enhancing lesions.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment